Yuefei Fang

6 ta ish

Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510450, China

1. Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

   Yang He, Yuefei Fang, Meng Zhang +7

   MaqolaHistone Deacetylase Inhibitors ResearchActa Pharmaceutica Sinica B20214 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.000056

2. Oral pectin/oligochitosan microspheres for colon-specific controlled release of quercetin to treat inflammatory bowel disease

   Shisuo Jing, Huayuan Chen, Ergang Liu +6

   MaqolaIL-33, ST2, and ILC PathwaysCarbohydrate Polymers20231 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.000081

3. Recombinant cell-penetrating trichosanthin synergizes anti-PD-1 therapy in colorectal tumor

   Meng Zhang, Ergang Liu, Guihua Chen +7

   MaqolaTransgenic Plants and ApplicationsInternational Journal of Biological Sciences20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.001168

4. Stimuli-responsive systems for smart drug delivery systems

   Akmal M. Asrorov, Yuefei Fang, Huiyuan Wang +2

   BobPhotochromic and Fluorescence ChemistryElsevier eBooks20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.chapter.000042

5. Contributors

   Omar A. Abdel Aziz, Ahmed S. Abo Dena, Abdul Ahad +85

   BobElsevier eBooks20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.chapter.000259

6. Asiatic acid cyclodextrin inclusion micro-cocrystal for insoluble drug delivery and acute lung injury therapy enhancement

   Huan Shen, Likun Pan, Keke Ning +4

   MaqolaCrystallography and molecular interactionsJournal of Nanobiotechnology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.000736